EN
Home/Guides/Choosing a provider
Guide 7 of 9 · Stage: Do it safely

Choosing where to get a GLP-1 in Canada: doctor, clinic or pharmacy

Family doctors, specialist programs, virtual clinics and pharmacy programs all prescribe or supply GLP-1 medicines. Here is how each route works, what you pay for, the rules they follow, and how to check one before you hand over your details.

GLP Guidebook teamUpdated 12 Oct 202614 min read22 sourcesWritten from published sources
The short answer

Start with your family doctor or nurse practitioner if you have one, and check what your public plan or insurance will pay. If you use a virtual clinic or program, choose one whose prescriber is licensed in your province, that looks at your health properly, fills prescriptions through a licensed pharmacy, and tells you the full monthly cost at your top dose before you pay. Never buy "research peptides", compounded versions or anything without a DIN.

Key facts

Who prescribes
  • Family doctors and nurse practitioners; no specialist needed1
  • In Alberta, some pharmacists with extra prescribing authority2
Virtual care
Same standard of care as in person, including prescribing3
Who pays
  • Weight management: no provincial plan (as of 12 Oct 2026); some private plans4,5
  • Type 2 diabetes: provincial plans cover semaglutide, with conditions6
Under watch
Health Canada has warned about fake, unauthorized and compounded GLP-1s since 20257,8,9
On this page
  1. Why are there so many providers?
  2. What kinds of provider are there?
  3. Will my plan pay?
  4. How does a virtual service run?
  5. What should each part look like?
  6. How do they charge?
  7. What are the rules in Canada?
  8. How do I check a provider?
  9. Checklist before you sign up
  10. Red flags
  11. Questions people ask
We don't name, rank or price providers. Canadian law bans advertising a drug to the public as a treatment for obesity or diabetes, and Health Canada says content is more likely to count as advertising when it favours a brand or is paid for by a seller.10,11 So this guide describes the kinds of provider and the rules they follow, so you can check any of them yourself. We take no money from any of them.

Why are there so many providers?

Weight-management brands arrived in quick succession, no public plan pays for them, and generics appeared in 2026. Many services grew up to fill the gap.

  • 2024Wegovy pens went on sale in Canada.12 Private insurers paid nearly $77 million for weight-management drugs that year, almost double the year before.5
  • Jul 2025Zepbound went on sale, after its approval in May 2025.12
  • Dec 2025Price talks for public coverage of Wegovy ended without agreement.4
  • May 2026The first generic semaglutide (for type 2 diabetes) reached pharmacies.13
  • Jun–Aug 2026Several national pharmacy chains launched weight-management programs with virtual access to prescribers and dietitians.14

Only a small number of private insurers cover these medicines for weight management, so many people pay themselves, and services compete for them.15

What kinds of provider are there?

Five main routes, plus sellers that operate illegally. They differ in who prescribes, what support you get, and who pays.

None of the routes is automatically safer. A careful virtual clinic can be better than a rushed in-person visit. What matters is whether the parts in the sections below are done properly.

1Your family doctor or nurse practitioner

They can prescribe any GLP-1 medicine; you don't need a specialist.1

Usually included
Your full history and other conditions, tests, and follow-up, in a visit your provincial health plan covers.
Suits
Anyone with a regular doctor, especially with diabetes, heart, kidney or other conditions to manage alongside.
Watch
Not everyone has a family doctor. If you don't, 811 in most provinces can tell you about local options.16
2Specialist obesity or bariatric program

Hospital and academic programs with a team of specialists, dietitians and others, usually by referral.1,17

Usually included
Specialist and dietitian care, and assessment for surgery if it might suit you.17
Suits
People with a higher BMI or several health problems, or who are weighing medicine against surgery.
Watch
You need a referral, and waits can be long.18
3Pharmacy chain weight-management program

Since mid-2026, some national pharmacy chains offer programs with virtual visits with physicians or nurse practitioners, and dietitian support, with the medicine filled at the pharmacy.14

Usually included
Virtual consultations, dietitian or coaching sessions, and dispensing; some say they are free to join, with the medicine paid separately.14
Suits
People without a family doctor who want a familiar pharmacy.
Watch
Which provinces it runs in, who prescribes, and what the medicine will cost at your top dose.
4Virtual weight clinic

Online-only services with doctors or nurse practitioners. Some charge for visits and for help with insurance forms, and ship medicine from a partner pharmacy.14

Usually included
Video or chat visits, prescriptions, insurance paperwork, delivery, and sometimes coaching or an app.14
Suits
People who want convenience, or live far from in-person care.
Watch
Whether the prescriber is licensed in your province, which pharmacy fills it, and whether a clinician reviews you when the dose changes.3
5Employer benefits and insurers

Group benefit plans that cover GLP-1s for weight usually set rules first: a prior authorization form, a BMI threshold or step therapy (trying other options first).5

Suits
Anyone with a benefits plan: ask your insurer in writing what it covers and what forms it needs.
Watch
Some services charge to fill in insurance forms; ask before you pay.14
Not a provider: "research peptide" websites, unlicensed sellers and compounded versions. Health Canada has warned that tirzepatide and retatrutide sold online as "peptides" are illegal, and that fake Ozempic and Mounjaro are sold in stores and online.8,7 It doesn't allow routine compounding of semaglutide, and a compounded product was recalled in 2025.9

Will my plan pay?

For weight management, probably not through a public plan. For type 2 diabetes, often yes, with conditions. Checked 12 Oct 2026.

  • Public plans and weight. No provincial plan covers Wegovy, Zepbound or Saxenda for weight management.4
  • Public plans and diabetes. Ontario, BC, Alberta, Quebec (RAMQ) and the federal NIHB program cover semaglutide for type 2 diabetes, usually after metformin; we found none that covers tirzepatide.6
  • Private plans. A small number cover weight management, usually with forms and rules.15,5
  • Quebec. Everyone must have drug insurance, through a group plan (assurance collective) or RAMQ's public plan.19

These are points to check, not a promise of coverage. Guide 4 has the plan-by-plan table, and Guide 6 the official prices.

How does a virtual service run?

Most follow the same steps. The ones to slow down at are the checks in steps 2 and 3.

1
Intake formYour health history, medicines, height and weight.
2
A real consultationWith a doctor or nurse practitioner licensed in your province, who considers whether you need a physical exam or tests.3
3
The prescriber decidesUsing the same standard of care as an in-person visit.3
4
Coverage and formsYour insurer may need a prior authorization form before it pays.5
5
Filled by a licensed pharmacyPicked up, or shipped cold and protected from freezing.7,20
6
Check-ins and refillsYour progress and side effects reviewed as the dose goes up, and regularly after.1

Based on the virtual-care standard of Ontario's College of Physicians and Surgeons and the Canadian obesity guideline.3,1

The steps look the same from the outside. The differences are in who does each one and how carefully, which the next section covers.

What should each part look like?

Six parts, each with what good looks like and the warning sign to watch for.

1The prescriber

2Your health check

  • Only a form, with nobody asking questionsVirtual care must meet the same standard as in person, including considering whether an exam is needed.3
    A live consultation, your weight and waist checked or confirmed, and tests where needed.1
  • Anyone accepted, at any weightThe weight labels start at a BMI of 30, or 27 with a weight-related condition.20
    The prescriber explains why a medicine fits you, using the guideline's measures, including ethnicity-specific ones.1

3Your family doctor and records

  • Nobody asks about your other careYour family doctor may be treating things that matter, such as diabetes or other medicines.
    The service asks about your medicines and conditions, and offers to share notes with your family doctor.

4The medicine

  • No DIN, a powder, or a pen that looks wrongHealth Canada says to check the 8-digit DIN, and warns about fakes with misused logos.7
    An approved pen or tablet in its packaging, with a DIN and leaflet, filled by a licensed pharmacy. If anything seems wrong, don't use it and report it to Canada Vigilance.
  • Shipped without protection from cold or heatPens must never freeze, and shouldn't sit above 30°C.20
    The service tells you how the pen is packed and what to do if it arrives frozen or warm. Guide 8 covers storage.

5Diet, coaching and the app

  • The medicine sold as the whole answerThe Canadian guideline recommends these medicines together with health behaviour changes, not instead of them.1
    Advice on eating enough protein and doing strength exercise to protect muscle (see Guide 8), ideally from a registered dietitian. Questions about side effects or your dose go to a clinician, not only an app or a coach.21

6Reviews and stopping

  • Doses keep going up with no reviewRefills sent on a timer, with no one asking how you are.
    Regular reviews of weight, health and side effects. The guideline notes the traditional check at 3 months on a full dose (5% lost), and says health gains count too.1 A plan for stopping is part of the service (see Guide 9).

How do they charge?

A visit to your family doctor is covered by your provincial health plan. The medicine is the biggest cost if no plan pays, and its price can rise as your dose goes up.

We don't publish any provider's prices. They change often and depend on the plan. Below is how the fees are built.14

The medicinePaid by your public plan, your insurer, or you, at the pharmacy's price. Guide 6 lists the official prices.
VisitsSome virtual clinics charge for a first visit or follow-ups; others don't. Pharmacy programs may be free to join.14
Insurance formsSome services charge a fee to complete an insurer's prior authorization form.14
ProgramsCoaching, dietitian sessions or an app, sometimes bundled with the visits.14
Ask one question before you pay: "What will I pay each month, all in, once I'm on my full dose?" A price on the starting dose can look cheaper than it will be. At Lilly's reported Canadian list prices, a 4-week supply of Zepbound is $300 at 2.5 and 5 mg but $420 at 7.5 and 10 mg.22 Savings-card or promotional prices aren't the list price. Then put your numbers into the GLP-1 cost calculator.

Budget in years, not months: Guide 9 explains what happens when you stop, and what years of treatment cost. A long prepaid program isn't automatically good value if you may need to stop or change medicine early.

What are the rules in Canada?

Every provider, online or not, works under the same rules on prescribing, pharmacies and advertising.

All GLP-1 medicines are prescription drugs.12 Doctors, nurse practitioners and pharmacies are licensed by their province.3,20

Virtual care (Ontario's standard, for example)
  • The same standard of care as in person, including for prescribing.3
  • The doctor must consider whether a physical exam is needed.3
  • For patients in another province, the doctor must follow that province's licensing rules.3

We didn't check every province's college one by one.

Who the labels are for
  • Wegovy and Zepbound: adults with a BMI of 30 or more, or 27 to 29.9 with at least one weight-related condition.20
  • Ozempic and Mounjaro are approved for type 2 diabetes; for weight they're off-label.12
Advertising
  • No one may advertise a drug to the public as a treatment for obesity or diabetes.10
  • Ads for prescription drugs to the public can only give the name, price and quantity.10
Enforcement
  • Health Canada warnings: fake and unauthorized GLP-1s (updated January 2026), illegal injectable "peptides" (August 2025), and a recalled compounded semaglutide (January 2025).7,8,9
  • We found no Canadian enforcement action against a named GLP-1 virtual clinic.

How do I check a provider?

Prescribers and pharmacies are licensed by provincial regulators, which keep public registers. Look them up before you share your details.

DoctorsSearch your province's college of physicians and surgeons, for example the CPSO in Ontario.3
Nurse practitionersSearch your province's nursing regulator.
PharmaciesSearch your province's pharmacy regulator. In Ontario, every pharmacy must be licensed by the Ontario College of Pharmacists, which has a public register.20
The productLook up the 8-digit DIN in Health Canada's Drug Product Database, and check the lot on the recalls site.7
Something went wrong?Report side effects or a suspect pen to Health Canada's Canada Vigilance Program (1-866-234-2345), and concerns about a professional to their provincial regulator.16

Checklist before you sign up

Tick as you go. Any box you can't tick is a question to ask before you pay.

Before you pay

At the consultation

Once you're in

For questions to ask about the medicine itself, use Guide 6's question list or the doctor-visit tool.

Red flags

Any one of these is a reason to stop and look elsewhere.

  • "No prescription needed"All GLP-1 medicines are prescription drugs in Canada.12
    Supplies only after a consultation and a prescription, through a licensed pharmacy.7
  • "Research peptides", retatrutide or a compounded versionRetatrutide isn't approved in Canada, and injectable "peptides" sold online are illegal.8 Routine compounding of semaglutide isn't allowed.9
    Supplies only approved medicines with a DIN, in their own packs.7
  • No real assessmentA form only, with no consultation.3
    A live consultation that considers whether you need an exam or tests.3
  • Sold for looks, or for a few kilos before a holidayThe weight labels cover obesity, or overweight with a weight-related condition.20
    Prescribes only when a medicine fits your health, and says no when it doesn't.
  • Ads promising weight loss with a named drugAdvertising a drug to the public as a treatment for obesity is banned in Canada.10
    Quotes trial results with the trial's name, length and dose, and says results vary. See Guide 2.

Already signed up and worried? Don't stop your medicine without talking to a doctor or pharmacist first. Report side effects or a suspect pen to the Canada Vigilance Program,16 and concerns about a professional to their provincial regulator.

Questions people ask

Before you sign up

Can my family doctor prescribe it, instead of a virtual clinic?

Yes. Family doctors and nurse practitioners can prescribe GLP-1 medicines; you don't need a specialist.1 The visit is covered by your provincial health plan; the medicine may not be.4

Is a virtual clinic as safe as my family doctor?

It can be. Virtual care must meet the same standard as in person, including when prescribing.3 What matters is a licensed prescriber, a real consultation, a licensed pharmacy and follow-up.

Will my insurance pay?

Maybe. Only a small number of private insurers cover these medicines for weight management, usually with a prior authorization form, a BMI threshold or step therapy.15,5 Ask your insurer in writing before you start.

Do I need a program, or just a prescriber?

You need a prescriber. A program adds coaching or dietitian support, which some people find helpful. The Canadian guideline recommends these medicines together with health behaviour changes, so support with eating and activity matters wherever it comes from.1

Once you're in

My pharmacy switched me to a generic. Is that OK?

In Ontario and Alberta, generic semaglutide is listed as interchangeable with Ozempic, so pharmacists may substitute it for type 2 diabetes.6 Ask to be shown how the new pen works, and check the lot isn't on the recalls list. See switching from Ozempic to a generic.

What should happen at my reviews?

The prescriber checks your weight, health and side effects. The Canadian guideline notes the traditional check at 3 months on a full dose, and says health gains can matter whatever the amount of weight lost.1

What if I'm told a GLP-1 isn't right for me?

That's the check working. Ask what to do instead; Guide 3 covers the other options.

Before you move on

  • Start with your family doctor if you have one, and check your coverage.
  • Find the prescriber and pharmacy on a provincial register.
  • Expect a real consultation, and a product with a DIN.
  • Get the all-in monthly cost at your full dose, in writing.
Getting a prescription, and the medicinesShould I consider a GLP-1?Stopping and the long term
Was this guide easy to understand?

Sources

  1. Pedersen SD, Manjoo P, Dash S, Jain A, Pearce N, Poddar M. Canadian Adult Obesity Clinical Practice Guideline: Pharmacotherapy for Obesity Management in Adults, 2025 update. Obesity Canada, Version 3, 11 August 2025; and Canada's Drug Agency SR0841 clinician input (any experienced provider can prescribe; not restricted to specialists). obesitycanada.ca (PDF) · canjhealthtechnol.ca
  2. Alberta College of Pharmacy. Additional prescribing authorization matters for safe pharmacy practice in Alberta. 24 February 2026. abpharmacy.ca
  3. College of Physicians and Surgeons of Ontario. Virtual Care policy, updated June 2022 (same standard of care, including prescribing; consider whether a physical examination is required; licensing in the patient's jurisdiction). cpso.on.ca
  4. BC PharmaCare. Drug coverage decision: semaglutide (Wegovy), 18 December 2025 ("Non-benefit"; pCPA negotiations concluded without agreement on 1 December 2025). Status of public plans checked 12 October 2026. gov.bc.ca (PDF)
  5. Benefits and Pensions Monitor. Can benefit plans stomach the $77 million weight-loss drug bill? (Telus Health data: insurers paid nearly $77m for weight-management drugs in 2024, almost double the $38m of 2023; plan controls such as prior authorization, BMI thresholds and step therapy). benefitsandpensionsmonitor.com
  6. Provincial drug plans for type 2 diabetes: Ontario Drug Benefit formulary (semaglutide Limited Use; generic interchangeable), BC PharmaCare semaglutide Special Authority (21 April 2026), Alberta Blue Cross Benefact 1330 (July 2026), Diabète Québec coverage table (RAMQ and NIHB, March 2026). Checked 12 October 2026. ODB · BC · AB · QC
  7. Health Canada. Thinking about buying GLP-1 drugs like Ozempic or Mounjaro? Beware of fake or unauthorized products (advisory RA-81518), updated 21 January 2026. recalls-rappels.canada.ca
  8. Health Canada. Unauthorized injectable peptide drugs seized and sold in Canada (advisory), 1 August 2025. recalls-rappels.canada.ca
  9. Alberta College of Pharmacy. Unauthorized compounding of semaglutide-containing products is not permitted (Health Canada policy POL-0051), 10 June 2025; Global News, compounded semaglutide recall, 22 January 2025. abpharmacy.ca · globalnews.ca
  10. Food and Drugs Act, section 3 and Schedule A.1 (obesity and diabetes), and Food and Drug Regulations, section C.01.044 (prescription-drug ads limited to name, price and quantity). Act · Regulations
  11. Health Canada. Distinction between advertising and other activities for health products (policy, 31 July 2023: message provider, sponsorship, manufacturer influence and balance of content). canada.ca
  12. Health Canada. Drug Product Database (all GLP-1 products "Prescription"; Wegovy FlexTouch first marketed 2024; Zepbound first authorized 13 May 2025, first marketed 9 July 2025; Ozempic and Mounjaro approved for type 2 diabetes). Searched 12 October 2026. health-products.canada.ca
  13. Global News / The Canadian Press. Generic semaglutide sales begin in Canada. 20 May 2026. globalnews.ca
  14. GLP Guidebook notes from the public pages and news releases of Canadian services, checked 12 October 2026: national pharmacy chains' weight-management programs (launched June and August 2026), virtual weight clinics and makers' patient programs. We did not sign up, take any quiz or share personal details. Providers are not named.
  15. Global News. Novo Nordisk to cut Ozempic price as generics arrive ("only a small number of private insurers cover the use of the drugs for weight management"). 26 May 2026. globalnews.ca
  16. Health Canada. Adverse reaction and medical device problem reporting (Canada Vigilance Program; phone 1-866-234-2345); Heart and Stroke Foundation, medical services by phone (811). canada.ca · heartandstroke.ca
  17. Glazer S, Biertho L. Canadian Adult Obesity Clinical Practice Guidelines: Bariatric Surgery: Selection & Pre-Operative Workup. Obesity Canada, Version 1, 4 August 2020 (multidisciplinary evaluation). obesitycanada.ca (PDF)
  18. Gill RS, Majumdar SR, Wang X et al. Prioritization and willingness to pay for bariatric surgery: the patient perspective. Can J Surg 2014;57(1):33–9 (long waits for publicly funded bariatric care). canjsurg.ca
  19. Gouvernement du Québec. Régime public d'assurance médicaments. quebec.ca
  20. Wegovy Product Monograph (2 October 2026) and Zepbound Product Monograph (11 June 2026): indications and storage (do not freeze; below 30°C limits); Ontario College of Pharmacists, Find a Pharmacy or Pharmacy Professional (every Ontario pharmacy must be licensed). Wegovy PM · Zepbound PM · ocpinfo.com
  21. Brown J, Clarke C, Johnson Stoklossa C, Sievenpiper J. Canadian Adult Obesity Clinical Practice Guidelines: Medical Nutrition Therapy in Obesity Management. Obesity Canada, Version 2, 21 October 2022 (individualized medical nutrition therapy from a registered dietitian). obesitycanada.ca (PDF)
  22. Benefits and Pensions Monitor (reporting The Globe and Mail). Eli Lilly cuts Canadian obesity drug prices (from 29 December 2025: $300 per 4-week supply for 2.5 and 5 mg; $420 for 7.5 and 10 mg). 19 December 2025. benefitsandpensionsmonitor.com

Last checked 12 Oct 2026 · Coverage and services re-checked every 3 months · Next full review due Jan 2027 · Report an error

How this guide was made. Written by the GLP Guidebook team from the sources above: Health Canada, provincial regulators and drug plans, the Canadian obesity guideline, named news reports and our own reading of provider websites. We don't name, rank or recommend any provider, and we take no money from drug companies, pharmacies, clinics or programs. It's general information, not medical advice. Talk to your family doctor, nurse practitioner or pharmacist before starting, stopping or changing any medicine. In an emergency, call 911. How we write